Global Cartilage Repair Market to reach a market size of $6.4 billion by 2024 - KBV Research

According to a new report Global Cartilage Repair Market, published by KBV research, The Global Cartilage Repair Market size is expected to reach $6.4 billion by 2024, rising at a market growth of 8.5% CAGR during the forecast period.

The North America market would dominate the Global Cell-Based Market by Region by 2024, growing at a CAGR of 7.1 % during the forecast period. The Europe market is expected to witness a CAGR of 7.5% during (2018 - 2024). Additionally, The Asia Pacific market is expected to witness a CAGR of 9.1% during (2018 - 2024).

The Intrinsic Repair Stimulus market dominated the Global Cartilage Repair Market by Treatment Type in 2017. The Palliative market is expected to witness highest CAGR of 9.2% during (2018 - 2024).

The Hyaline Cartilage market dominated the Global Cartilage Repair Market by Application in 2017, and would achieve a market value of $3,393.1 million by 2024. The Fibrocartilage market is expected to witness a CAGR of 9.3% during (2018 - 2024).

Full Report: https://www.kbvresearch.com/cartilage-repair-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of B. Braun Melsungen AG, Zimmer Biomet, Johnson and Johnson, Smith & Nephew Plc., Stryker Corporation, Vericel Corporation, Osiris Therapeutics Inc., Arthrex, Inc., Collagen Solutions Plc., and Anika Therapeutics, Inc.

Global Cartilage Repair Market Segmentation

By Modality

• Cell-Based:

• Chondrocyte Transplantation    
• Growth Factor Technology

• Non-Cell-Based

• Tissue Scaffolds
• Cell-Free Composites

By Treatment type

• Intrinsic Repair Stimulus
• Palliative

• Debridement & Lavage
• Viscosupplementation

By Application

• Fibrocartilage
• Hyaline Cartilage

By Site outlook

• Knee Cartilage Repair

• Microfracture
• Arthroscopic Chondroplasty
• Autologous Chondrocyte
• Osteochondral Grafts Transplantation
• Cell-based Cartilage Resurfacing
• Others

• Other Site Outlook

 By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• B. Braun Melsungen AG
• Zimmer Biomet
• Johnson and Johnson
• Smith & Nephew Plc.
• Stryker Corporation
• Vericel Corporation
• Osiris Therapeutics Inc.
• Arthrex, Inc.
• Collagen Solutions Plc.
• Anika Therapeutics, Inc.

Unique Offerings from KBV Research

• Exhaustive coverage  
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Related Reports:

North America Market Report

Europe Market Report

Asia Pacific Market Report

LAMEA Market Report